ПРОТИВОГРИБКОВЫЕ ЛЕКАРСТВЕННЫЕ СРЕДСТВА ДЛЯ ЛЕЧЕНИЯ ВАГИНАЛЬНОГО КАНДИДОЗА

2024

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.53729/mv-as.2024.01.06
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Fungal infections can significantly alter the normal microflora of the body. Long-term use of ineffective medications in the treatment of vaginal candidiasis leads to drug resistance of infectious agents, and their systemic absorption leads to metabolic disorders. The transition of the disease to chronic forms in some cases causes infertility or the need for termination of pregnancy. The article discusses the modern most effective and safest drugs based on the recommendations of attending physicians and patient reviews. Грибковые инфекции способны значительно изменять нормальную микрофлору организма. Длительное применение малоэффективных медицинских препаратов в лечении вагинального кандидоза приводит к лекарственной устойчивости возбудителей инфекции, а их системное всасывание - к процессам нарушения метаболизма. Переход заболевания в хронические формы в некоторых случаях вызывает бесплодие или к необходимости прерывания беременности. В статье рассмотрены современные наиболее эффективные и максимально безопасные препараты на основе рекомендаций лечащих врачей и отзывов пациентов.